Print Page   |   Contact Us   |   Sign In   |   Become a Member
Site Search
New Investigator Programs
Share |

ISEH continues to provide opportunities for new scientists to grow in their careers, including facilitating and mentoring relationships with established ISEH scientists.

NI Lecture | NI Meet the Expert Breakfast | NI Mixer | NI Career Panel Sessions


New Investigator Lecture

Saturday, 23 August 2014

The New Investigator Committee is sponsoring an invited speaker session featuring Simón Méndez-Ferrer, Ph.D. from the National Cardiovascular Research Center (CNIC, Madrid, Spain).

Simón Méndez-Ferrer’s research has connected the brain and signals that are released from the nervous system to the bone marrow stroma. His Ph.D. in Neuroscience characterized neurotrophic properties of neural crest-derived cells. This background made him interested in the neural regulation of hematopoiesis. Working with Paul S. Frenette he showed that hematopoietic stem cell traffic is regulated by circadian oscillations. His work also identified nestin+ mesenchymal stem cells in the bone marrow and determined their crucial role in the hematopoietic stem cell niche. Dr. Méndez-Ferrer is an Assistant Professor at the National Cardiovascular Research Center (CNIC, Madrid, Spain) and an Adjunct Assistant Professor at the Icahn School of Medicine at Mount Sinai, New York. He is supported in part by an International Early Career Scientist grant of the Howard Hughes Medical Institute.

Meet the Expert Breakfast

Friday, 22 August 2014 

Join an expert for breakfast. Save your seat with your preferred expert when you complete meeting registration. Below is a list of confirmed expert:

 

· Sean Morrison, UT Southwestern Medical Center, Texas - TABLE FULL

· Scott Armstrong, Memorial Sloan Kettering Cancer Center, New York - TABLE FULL

· George Daley, Harvard Stem Cell Institute and Boston Children’s Hospital - TABLE FULL

· Connie Eaves, Terry Fox Laboratory, Vancouver.

Recipient of the 2014 ISEH Metcalf Award

· Toshio Suda, Keio University, Japan.

Recipient of the 2014 ISEH Till and McCulloch Award

· Emmanuelle Passegue, UC San Francisco - TABLE FULL


New Investigator Mixer

Friday, 22 August 2014 

Take the chance to socialize with other new investigators from around the world during an evening of mingling and drinks at the Six Resto Lounge at the Hyatt Regency Hotel. To participate, add the New Investigator Mixer to your meeting registration for the small additional cost of $25.00 (USD). Tickets include 1 hour of light snacks and drinks. 

New Investigator Career Panel Discussions

Session 1: Alternative Careers
Friday, 22 August 2014

Interested in learning more about alternative careers in hematology and stem cells? Come meet experts in scientific funding, science editing, biotech, and pharma. An outstanding panel will share their experiences transitioning from academia to successful careers at CIHR, Cell Stem Cell, Stem Cell Technologies, and Jansen Pharmaceuticals. These sessions are highly interactive and informative, so come prepared to ask everything you wanted to know about life outside of academia. 

Speakers:

                                                                                    
Steve Szilvassy - StemCell Technologies

Dr. Szilvassy began his career in the field of hematopoietic stem cell biology in 1985 as a Ph.D. student at the Terry Fox Laboratory in Vancouver.  He then did his postdoctoral training at the Walter & Eliza Hall Institute in Melbourne, after which he returned to the USA to work as a scientist at a mid-size biotechnology company.  This was followed by 7 years as a tenured Associate Professor of Medicine at the University of Kentucky, 9 years as Principal Scientist in Hematology/Oncology at Amgen, the world's largest biotechnology company, and finally his present position as Director of Hematopoietic Product R&D at STEMCELL Technologies.

 
                                                                           
Nicolay Ferrari - CCCTG

Dr. Nicolay Ferrari completed his graduate studies at the Université de Montréal in 1999. He then pursued his post-doctoral work at the Dana-Farber Cancer Institute of the Harvard Medical School (Boston MA) and at the National Cancer Institute of the National Institutes of Health (Bethesda MD) developing anti-angiogenic gene therapy approaches and the use of neuronal stem cells as delivery vehicles of therapeutic genes for the treatment of brain tumors. Dr. Ferrari recently completed a Graduate Diploma in Management and Business from McGill in 2012. Following his postdoctoral studies, he spent 12 years in the biotechnology sector, first at Celmed Biosciences as Group Leader and then at Topigen Pharmaceuticals. At Topigen, as Director Pharmacology, he provided leadership for discovery and preclinical research activities that lead to the development of three novel anti-inflammatory drug candidates for the treatment of respiratory diseases, one currently in Phase 2 for the treatment of asthma. Since 2011, Dr. Ferrari is a Lecturer at the Department of Pharmacology at the Université de Sherbrooke. Just prior to joining the Canadian Critical Care Trial Group as the Executive Director in 2013, Dr. Ferrri was the Assistant Director of the Institute of Cancer Research of the Canadian Institutes of Health Research where he assisted the development of novel funding opportunities and public-private partnerships. 

Dr. Sheila Chari - Cell Press

Dr. Sheila Chari completed her undergraduate studies in biology at the University of Illinois at Urbana-Champaign before moving to Chicago for graduate school at Northwestern University Feinberg School of Medicine. After completing a Ph.D studying transcriptional regulation of T cell development and leukemia, she joined the lab of Dr. Bruce Lahn at the University of Chicago to pursue postdoctoral studies in epigenetic regulation of cancer and somatic cell reprogramming. In 2012, she joined Cell Press as Reviews Editor with Cell Stem Cell. She is currently an Associate Editor with the journal.


 

Session 2: Omics: A Practical Guide

Sunday, 24 August 2014

Performing omics analysis on small cell populations is a major challenge for hematology and stem cell researchers. Come meet the scientists in the trenches of cutting edge omics in our field. This session is aimed at answering all your practical questions on performing various high-throughput sequencing techniques from the scientists developing the protocols for the study of hematopoietic stem cells and other rare cell populations. 

Speakers:

 
1. Simon Haas - Single Cell RNA SequencingSimon Haas performed his undergraduate studies in Molecular Biosciences and Biochemistry at the University of Heidelberg and the Imperial College London. During his studies, Simon received practical training in molecular biology, epigenetics and stem cell biology at Massachusetts Institute of Technology, Imperial College London and German Cancer Research Center working on long non-coding RNAs and various aspects of stem cell biology. He is currently pursuing his Ph.D. at the German Cancer Research Center in the group of Dr. Marieke Essers and the division of Prof. Dr. Andreas Trumpp focusing on hematopoietic stem cell fate decisions and single-cell approaches.

2. 
Daniel Lipka - Tagmentation and DNA Methylation - Dr. Daniel Lipka studied medicine at the Universities of Heidelberg (Germany) and Madrid (Spain). He completed is training in Internal Medicine at the University Medical Centers of Ulm and Mainz in Germany and then moved to the University Medical Center in Magdeburg to specialize in Hematology/Oncology in the program lead by Prof. Thomas Fischer. He then chose to leave clinical practice in order to pursue his growing interest in medical research and took up a position within the Division of Epigenomics and Cancer Risk Factors at the German Cancer Research Center (DKFZ) under the guidance of Prof. Christoph Plass. Daniel’s scientific research focuses on how the epigenome regulates the biology of both normal and malignant hematopoiesis. One major technical barrier in this field of research, which limits the study of rare stem cell/cancer stem cell populations, is the relatively large amounts of input material that is required to perform true genome wide sequencing analysis following chromatin immunoprecipitation or bisulphite conversion. Daniel has successfully employed a number of technologies in order to facilitate whole epigenome studies using limited input material from hematopoietic stem and progenitor cells and these will be discussed in the workshop.

3. 
Gerald de Haan - Viral Barcoding -Prof. Gerald de Haan was a graduate student at the University of Cologne and Groningen, working on the regulation of blood cell production by growth factors. He was a postdoc at the University of Kentucky where he worked with Gary Van Zant on stem cell aging, and returned to the Netherlands as a fellow of the Royal Netherlands Academy of Sciences. He established his own lab at the Department of Cell Biology at the University of Groningen, where he was appointed full professor in 2005. He led the team of University of Groningen scientists that developed and designed the European Research Institute for the Biology of Ageing, of which he is current Co-Director. In addition he acts as dean of the Learning Community "Molecular Medicine" in the Bachelor program of the Medical School of the University of Groningen.  

 

 

 

Association Management Software Powered by YourMembership  ::  Legal